AKT1 and non-small cell lung carcinoma: With the aim of discovering new molecular targets in the management of non-small cell lung cancer (NSCLC), research has focused mainly on the link between the PI3K/AKT/mTOR signaling pathway and lung cancer development as it affects many aspects related to cell survival, proliferation, differentiation, motility and growth [127].